IHH Healthcare (IHH)

Sustainability

IHH Healthcare announces sustainability commitments in launch of first standalone sustainability report

IHH’s sustainability goals were set out across four stakeholder pillars, which are "patients", "people", "public" and "planet".

Healthcare

Large-cap healthcare stocks: Hefty, hearty and healthy

Covid-19 may be over, but these hospital players are still seeing growth from the economic recovery.
IHH Healthcare reports FY2022 earnings of RM1.55 bil, 16.9% lower y-o-y - THE EDGE SINGAPORE

Results

IHH Healthcare reports FY2022 earnings of RM1.55 bil, 16.9% lower y-o-y

A first and final dividend of 2.16 cents has been declared for the year.

Healthcare

PLife REIT and IHH Healthcare conduct major refurbishment works at Mount Elizabeth Hospital

The project, which will cost $350 million, will be jointly funded by both PLife REIT and IHH Healthcare.
Private hospitals may benefit from rise in Covid-19 cases: DBS - THE EDGE SINGAPORE

Broker's Calls

Private hospitals may benefit from rise in Covid-19 cases: DBS

DBS has kept “buy” on Raffles Medical Group and IHH Healthcare with target prices of $1.63 and RM7.90 ($2.37) respectively.

Healthcare

IHH Healthcare says no wrongdoing found in Fortis investment

In its statement, IHH expressed its commitment to “stand firm” on Fortis’ side to “continue this growth journey”.
IHH has 'plenty [of] opportunities to grow' despite termination of Ramsay Sime-Darby acquisition: CGS-CIM - THE EDGE SINGAPORE

Broker's Calls

IHH has 'plenty [of] opportunities to grow' despite termination of Ramsay Sime-Darby acquisition: CGS-CIMB

CGS-CIMB is keeping its 'add' call and target price of RM8.07 ($2.50) on IHH.

M&A

Discussions between IHH to acquire Ramsay Sime Darby Health Care Sdn Bhd have been terminated

IHH Healthcare, on March 22, announced that it has proposed to acquire 100% of Ramsay Sime Darby Health Care Sdn Bhd
Analysts optimistic on IHH Healthcare on further recovery in core businesses - THE EDGE SINGAPORE

Broker's Calls

Analysts optimistic on IHH Healthcare on further recovery in core businesses

IHH is currently trading at a very attractive FY22 EV/ebitda of 14x, close to -2 SD of its historical range.
×